Where to buy Trelagliptin succinate

Since the Trelagliptin (Trelagliptin) original drug has not yet received relevant approval for marketing in China and cannot be covered by medical insurance, patients cannot yet purchase Trelagliptin in domestic hospitals or pharmacies. The available evidence to date for trotagliptin suggests that it is effective when given once weekly to treat type 2 diabetes. In a phase 1 study, trolagliptin was shown to inhibit DPP-4 activity for up to 7 days.

In a Phase 2 study, 12 weeks of trolagliptin treatment produced dose-dependent improvements in glycemic control, with trolagliptin at the highest dose of 200 mg significantly reducing HbA1c compared with placebo. At a dose of 100 mg, the average inhibition rate of DPP-4 also remained approximately 80% 7 days after administration. In the Phase 3 study, trolagliptin showed similar efficacy and safety to alogliptin. There was no significant difference in the DPP-4 inhibition rate of the 100 mg trotagliptin group 7 days after administration and the DPP-4 inhibition rate of the alogliptin group 1 day after administration.

The original drug of trotagliptin is developed and produced by Japan's Takeda Pharmaceutical Factory and is on the market. The specification is 50mg*20 tablets and the price per box may be around RMB 1,000 (the price may fluctuate due to the exchange rate). There are also generic versions of Tretagliptin produced in other countries. The ingredients are basically the same as those of the original drug. For example, the price of 100mg*21 tablets produced by a Bangladesh pharmaceutical factory may be several hundred yuan per box (the price may fluctuate due to exchange rate effects). Patients can choose to purchase it through formal channels according to their needs. For more drug information and specific prices, please consult Yaode Medical Consultant.